🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine if conversion to enteric coated MPA allows an escalated dose o...
Status
Terminated
Location
Novartis
Start Date
2008-03
Trial ID
NCT00658333
The purpose of this research study is to see if a study drug called Tociliz...
Status
Completed
Location
Cedars Sinai Medical Center (CACS)
Start Date
2018-12-20
Trial ID
NCT03644667
Treatments Being Tested
The purpose of this study was to evaluate whether delayed (i.e. 28 ± 4 days...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-11
Trial ID
NCT01410448
Treatments Being Tested
Induction therapy decreases the rate of acute allograft rejection in kidney...
Status
Recruiting
Location
01-TOURS
Start Date
2023-11-07
Trial ID
NCT05385432
Treatments Being Tested
To demonstrate that cyclosporine-sparing immunosuppressions with the standa...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01817322
Mycophenolate sodium (Myfortic®) is a newly developed enteric-coated tablet...
Status
Completed
Location
Cedars- Sinai Medical Center
Start Date
2006-06
Trial ID
NCT00574197
Treatments Being Tested
The aim of this study is to assess the safety and efficacy of corticosteroi...
Status
Completed
Location
Royal Prince Alfred Hospital
Start Date
2006-03
Trial ID
NCT00371826
The aims of this study are to extensively study the levels of CD25-Receptor...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01596062
Treatments Being Tested
The aims of the study was to evaluate the safety and efficacy of early intr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12
Trial ID
NCT01625377
Treatments Being Tested
The purpose of this study is to compare renal function of immunosuppressive...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-07
Trial ID
NCT00514514
Treatments Being Tested